Dupilumab in Chinese Adult Participants With CRSwNP
Clinical trial NCT05878093 · COMPLETED
Trial details
- NCT number
- NCT05878093
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-16
- Primary completion
- 2024-09-06
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.